123 related articles for article (PubMed ID: 6099839)
1. Angiotensin-producing enzyme I of serum: formation by immunization with renin.
Haas E; Lewis LV; Scipione P; Koshy TJ; Varde AU; Renerts L
J Hypertens; 1984 Apr; 2(2):131-40. PubMed ID: 6099839
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-producing enzyme III from acidified serum of nephrectomized dogs.
Haas E; Lewis L; Koshy TJ; Varde AU; Renerts L; Bagai RC
Am J Hypertens; 1989 Sep; 2(9):696-707. PubMed ID: 2572242
[TBL] [Abstract][Full Text] [Related]
3. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes.
Hackenthal E; Hackenthal R; Hilgenfeldt U
Biochim Biophys Acta; 1978 Feb; 522(2):574-88. PubMed ID: 623774
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-producing enzyme III from acidified serum of nephrectomized dogs. Activation of proenzyme III to enzyme III by cathepsin G.
Haas E; Lewis L; Koshy TJ; Varde AU; Renerts LV; Bagai RC
Am J Hypertens; 1989 Sep; 2(9):708-14. PubMed ID: 2803676
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin generation in the brain and drinking: indications for the involvement of endopeptidase activity distinct from cathepsin D.
Tonnaer JA; Wiegant VM; De Jong W
Brain Res; 1981 Nov; 223(2):343-53. PubMed ID: 7025965
[TBL] [Abstract][Full Text] [Related]
6. A novel nonpeptidic, orally active renin inhibitor.
Morishima H; Koike Y; Nakano M; Atsuumi S; Tanaka S; Funabashi H; Hashimoto J; Sawasaki Y; Mino N; Nakano M
Biochem Biophys Res Commun; 1989 Mar; 159(3):999-1005. PubMed ID: 2495004
[TBL] [Abstract][Full Text] [Related]
7. Highly potent and specific inhibitors of human renin.
Kokubu T; Hiwada K; Murakami E; Imamura Y; Matsueda R; Yabe Y; Koike H; Iijima Y
Hypertension; 1985; 7(3 Pt 2):I8-11. PubMed ID: 2987128
[TBL] [Abstract][Full Text] [Related]
8. Preparation of a specific high-titer antibody against rat kidney renin.
Figueiredo AF; Inagami T
Braz J Med Biol Res; 1985; 18(2):151-5. PubMed ID: 3913477
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-producing serum enzyme II. Formation by inhibitor removal and proenzyme activation.
Haas E; Lewis LV; Scipione P; Koshy TJ; Varde AU; Renerts L
Hypertension; 1985; 7(6 Pt 1):938-47. PubMed ID: 3908315
[TBL] [Abstract][Full Text] [Related]
10. Activation of human inactive ("pro-") renin by cathepsin D and pepsin.
Morris BJ
J Clin Endocrinol Metab; 1978 Jan; 46(1):153-7. PubMed ID: 376540
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the substrate specificities of cathepsin D and pseudorenin.
Dorer FE; Lentz KE; Kahn JR; Levine M; Skeggs LT
J Biol Chem; 1978 May; 253(9):3140-2. PubMed ID: 641059
[TBL] [Abstract][Full Text] [Related]
12. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II.
Karlsson C; Lindell K; Ottosson M; Sjöström L; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1998 Nov; 83(11):3925-9. PubMed ID: 9814470
[TBL] [Abstract][Full Text] [Related]
13. Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.
Wilczynski EA; Osmond DH
Hypertension; 1983; 5(3):277-85. PubMed ID: 6341216
[TBL] [Abstract][Full Text] [Related]
14. Renin activity in dog brain: enzymological similarity to cathepsin D.
Day RP; Reid IA
Endocrinology; 1976 Jul; 99(1):93-100. PubMed ID: 181241
[TBL] [Abstract][Full Text] [Related]
15. Antibodies as specific renin inhibitors: studies with polyclonal and monoclonal antibodies and Fab fragments.
Dzau VJ; Devine D; Mudgett-Hunter M; Kopelman RI; Barger AC; Haber E
Clin Exp Hypertens A; 1983; 5(7-8):1207-20. PubMed ID: 6357564
[TBL] [Abstract][Full Text] [Related]
16. Micromethod for the assay of renin of seven species.
Haas E; Lewis L; Scipione P; Koshy TJ
Hypertension; 1979; 1(2):112-7. PubMed ID: 399936
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin I conversion by human and rat chymotryptic proteinases.
Wintroub BU; Schechter NB; Lazarus GS; Kaempfer CE; Schwartz LB
J Invest Dermatol; 1984 Nov; 83(5):336-9. PubMed ID: 6092480
[TBL] [Abstract][Full Text] [Related]
18. Statine-containing dipeptide and tripeptide inhibitors of human renin.
Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
[TBL] [Abstract][Full Text] [Related]
19. All of the components required for angiotensin II formation are expressed locally in human atherosclerotic lesions, including a long suspected player cathepsin G.
Whitman SC
J Hypertens; 2004 Jan; 22(1):39-42. PubMed ID: 15106791
[No Abstract] [Full Text] [Related]
20. Renin and angiotensin-converting enzyme in human neuroblastoma tissue.
Mizuno K; Ojima M; Hashimoto S; Fukuchi S
J Neurochem; 1985 Aug; 45(2):626-9. PubMed ID: 2989431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
